Name: Cancer Stem Cell Therapy Market Size Share Growth and Report 2024-2031
Creator: DataM Intelligence
Published: Tue Jun 18 2024 11:01:05 GMT+0530 (India Standard Time)
License: https://www.datamintelligence.com/terms-conditions

Cancer Stem Cell Therapy Market Size Share Growth and Report 2024-2031

Cancer Stem Cell Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Cancer Stem Cell Therapy Market&nbsp;Size, Share &amp; Trends Analysis Report By Therapy Type, By Cancer Type, By End-user, By Region, And Segment Forecasts, 2024 &ndash; 2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global Cancer Stem Cell Therapy Market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Stem cell therapy is a regenerative medicine that repairs damaged cells by reducing inflammation and modulating the immune system, making it a viable treatment option for various medical conditions. Stem cell transplantation is a cancer treatment that restores stem cells responsible for blood-forming in patients who have had their blood-forming stem cells destroyed through radiotherapy or chemotherapy.&nbsp;

This treatment is used to treat leukaemia, lymphoma, neuroblastoma, and multiple myeloma. In a stem cell transplant, the patient receives healthy blood-forming stem cells through a vein, which travel to the bone marrow to replace the cells destroyed by treatment. Transplants can be autologous, allogeneic, or syngeneic.&nbsp;

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Therapy Type, Cancer Type, End User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

 
&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/cancer-stem-cell-therapy-market" target="_blank">Request for Sample</a>

&nbsp;

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Rise in the prevalence of cancer cases

The global increase in cancer cases due to efficient disease treatment is driving demand for the cancer stem cells market. Cancer stem cell therapy targets specific cancer cells to eliminate post-treatment cancer. It involves intricate processes like genetic modulation, cell isolation, and personalized treatment planning. These factors collectively contribute to the growth of the cancer stem cell market.

For instance, each year, the American Cancer Society estimates the number of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States.&nbsp;

High costs associated with the treatment

Cancer stem cell therapy development necessitates extensive research, clinical trials, and preclinical investigations, resulting in high costs and increased expenditure. This leads to a higher retail price of the drug upon approval, limiting the growth of the cancer stem cell market. The high cost of cancer treatment is a significant barrier to its development.

<h3>Segment Analysis</h3>

The global cancer stem cell therapy market is segmented based on therapy type, cancer type end-user and region.

The autologous stem cell transplants from the therapy type segment accounted for approximately 52.3% of the cancer stem cell therapy&nbsp; market share

The autologous stem cell transplants from the therapy type segment accounted for approximately 42.3%. Autologous stem cell transplants are typically used in people who need to undergo high doses of chemotherapy and radiation to cure their diseases. These treatments are likely to damage the bone marrow. An autologous stem cell transplant helps to replace the damaged bone marrow.

For instance, in September 2023, BioLineRx Ltd. a commercial-stage biopharmaceutical company focused on certain cancers and rare diseases, announced that the U.S. Food and Drug Administration (FDA) has approved APHEXDA (motixafortide) in combination with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma. APHEXDA is administered by injection, for subcutaneous use.

<h3>Geographical Analysis</h3>

North America is estimated to hold about 43.4% of the total market share throughout the forecast period 

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the established healthcare sector, developed economies like the US and Canada investing in chronic disease treatment, and the presence of major pharmaceutical companies and research centers. Also, technologically advanced healthcare infrastructure and biomedical research centers are actively researching various cancer treatment methods, contributing to the market&#39;s growth.&nbsp;

For instance, in March 2024, Stanford Medicine became the first center in the nation to treat a patient with metastatic melanoma using a new cell-based therapy approved by the Food and Drug Administration. The therapy, which offers hope for people with advanced melanoma whose cancers have resisted immunotherapies, is the first cell-based therapy approved by the FDA to treat solid tumors.

<h3>Covid 19 Impact Analysis</h3>

The COVID-19 pandemic significantly impacted the market, leading to increased focus on healthcare and biomedical research. Funding agencies and governments allocated resources for research, including cancer stem cell therapy. The pandemic also prompted researchers to adapt and innovate, resulting in new strategies and collaborations.&nbsp;

<h3>Market Segmentation</h3>

By Product Type

<ul>
	<li>Autologous Stem Cell Transplants</li>
	<li>Allogeneic Stem Cell Transplants</li>
	<li>Syngeneic Stem Cell Transplants</li>
	<li>Others</li>
</ul>

By Cancer Type

<ul>
	<li>Breast Cancer</li>
	<li>Bladder Cancer</li>
	<li>Blood Cancer</li>
	<li>Lung Cancer</li>
	<li>Brain Cancer</li>
	<li>Others</li>
</ul>

By End User

<ul>
	<li>Hospitals</li>
	<li>Clinics</li>
	<li>Academic and Research Institutes</li>
	<li>Others</li>
</ul>

By Region

<ul>
	<li>North America
	<ul>
		<li>U.S.</li>
		<li>Canada</li>
		<li>Mexico</li>
	</ul>
	</li>
	<li>Europe
	<ul>
		<li>Germany</li>
		<li>UK</li>
		<li>France</li>
		<li>Italy</li>
		<li>Spain</li>
		<li>Rest of Europe</li>
	</ul>
	</li>
	<li>South America
	<ul>
		<li>Brazil</li>
		<li>Argentina</li>
		<li>Rest of South America</li>
	</ul>
	</li>
	<li>Asia-Pacific
	<ul>
		<li>China</li>
		<li>India</li>
		<li>Japan</li>
		<li>South Korea</li>
		<li>Rest of Asia-Pacific</li>
	</ul>
	</li>
	<li>Middle East and Africa</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the market include Thermo Fisher Scientific, Inc., Advanced Cell Diagnostics, Silicon Biosystems, Celularity Inc., Gamida Cell Ltd, Sumitomo Dainippon Pharma Co. Ltd, Merck KGaA, Genentech Inc., Astellas Pharma Inc., Novadip Biosciences among others.

<h3>Key Developments</h3>

<ul>
	<li>In February 2024, Thumbay University Hospital launched the Cancer Center at Thumbay University in Al Jurf, Ajman. The fully equipped centre will be active by the end of February 2024. The rising demand for cancer treatment and screening in the Northern Emirates resulted in the launch of these centres. The cancer centre will offer affordable cancer care focusing on multidisciplinary treatment.&nbsp;</li>
	<li>In January 2024, Glenmark Pharma, in collaboration with Ichnos Science, announced the Ichnos Glenmark Innovation (IGI) to increase drug delivery in cancer treatment.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global cancer stem cell therapy market segmentation based on therapy type, cancer type, end user and region as well as understand key commercial assets and players.</li>
	<li>identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>excel data sheet with numerous data points of the cancer stem cell therapy market level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global cancer stem cell therapy market report would provide approximately 64 tables, 61 figures and 186 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Market Snippet by Product Type</li>
		<li>Market Snippet by Application Type</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing incidence of cancer cases</li>
				<li>Emerging strong pipeline of new drugs</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Major side-effects of stem cell transplants</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	<h3>COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>By Product Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Attractiveness Index, By Product Type</li>
		</ol>
		</li>
		<li>Autologous Stem Cell Transplants*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Allogeneic stem cell transplant</li>
		<li>Syngeneic stem cell transplant</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3>By Application Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type</li>
			<li>Market Attractiveness Index, By Application Type</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Clinics</li>
		<li>Medical research institutes</li>
		<li>Other</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>Thermo Fisher Scientific, Inc*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>AVIVA BioSciences,</li>
		<li>AdnaGen,</li>
		<li>Advanced Cell Diagnostics,</li>
		<li>Silicon Biosystems,</li>
		<li>Cellerant Therapeutics, Inc,</li>
		<li>Celularity Inc,</li>
		<li>Gamida Cell Ltd,</li>
		<li>Nohla Therapeutics, Inc,</li>
		<li>Sumitomo Dainippon Pharma Co. Ltd.(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	<h3>DataM Intelligence</h3>

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Cancer Stem Cell Therapy Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Cancer Stem Cell Therapy Market Value, By Cancer Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Cancer Stem Cell Therapy Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Cancer Stem Cell Therapy Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Cancer Stem Cell Therapy Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Cancer Stem Cell Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Cancer Stem Cell Therapy Market Value, By Cancer Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Cancer Stem Cell Therapy Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 9 Global Cancer Stem Cell Therapy Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Cancer Stem Cell Therapy Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Cancer Stem Cell Therapy Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Cancer Stem Cell Therapy Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Cancer Stem Cell Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Cancer Stem Cell Therapy Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 15 North America Cancer Stem Cell Therapy Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Cancer Stem Cell Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 17 Asia-Pacific Cancer Stem Cell Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 Asia-Pacific Cancer Stem Cell Therapy Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 19 Asia-Pacific Cancer Stem Cell Therapy Market Value, By End User, 2022-2031 (US$ Million)

Table 20 Asia-Pacific Cancer Stem Cell Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Cancer Stem Cell Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Cancer Stem Cell Therapy Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 23 Europe Cancer Stem Cell Therapy Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Cancer Stem Cell Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 25 South America Cancer Stem Cell Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 South America Cancer Stem Cell Therapy Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 27 South America Cancer Stem Cell Therapy Market Value, By End User, 2022-2031 (US$ Million)

Table 28 South America Cancer Stem Cell Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East and Africa Cancer Stem Cell Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East and Africa Cancer Stem Cell Therapy Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 31 Middle East and Africa Cancer Stem Cell Therapy Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Middle East and Africa Cancer Stem Cell Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 33 Thermo Fisher Scientific, Inc: Overview

Table 34 Thermo Fisher Scientific, Inc: Product Portfolio

Table 35 Thermo Fisher Scientific, Inc: Key Developments

Table 36 Advanced Cell Diagnostics: Overview

Table 37 Advanced Cell Diagnostics: Product Portfolio

Table 38 Advanced Cell Diagnostics: Key Developments

Table 39 Silicon Biosystems: Overview

Table 40 Silicon Biosystems: Product Portfolio

Table 41 Silicon Biosystems: Key Developments

Table 42 Celularity Inc: Overview

Table 43 Celularity Inc: Product Portfolio

Table 44 Celularity Inc: Key Developments

Table 45 Gamida Cell Ltd: Overview

Table 46 Gamida Cell Ltd: Product Portfolio

Table 47 Gamida Cell Ltd: Key Developments

Table 48 Sumitomo Dainippon Pharma Co. Ltd: Overview

Table 49 Sumitomo Dainippon Pharma Co. Ltd: Product Portfolio

Table 50 Sumitomo Dainippon Pharma Co. Ltd: Key Developments

Table 51 Merck KGaA: Overview

Table 52 Merck KGaA: Product Portfolio

Table 53 Merck KGaA: Key Developments

Table 54 Genentech Inc: Overview

Table 55 Genentech Inc: Product Portfolio

Table 56 Genentech Inc: Key Developments

Table 57 Astellas Pharma Inc: Overview

Table 58 Astellas Pharma Inc: Product Portfolio

Table 59 Astellas Pharma Inc: Key Developments

Table 60 Novadip Biosciences: Overview

Table 61 Novadip Biosciences: Product Portfolio

Table 62 Novadip Biosciences: Key Developments

List of Figures

Figure 1 Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 2 Global Cancer Stem Cell Therapy Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 3 Global Cancer Stem Cell Therapy Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 4 Global Cancer Stem Cell Therapy Market Share, By End User, 2023 &amp; 2031 (%)

Figure 5 Global Cancer Stem Cell Therapy Market Share, By Region, 2023 &amp; 2031 (%)

Figure 6 Global Cancer Stem Cell Therapy Market Y-o-Y Growth, By Product Type, 2023-2031 (%)

Figure 7 Autologous Stem Cell Transplants Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 8 Allogeneic Stem Cell Transplants Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 9 Syngeneic Stem Cell Transplants Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 10 Others Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 11 Global Cancer Stem Cell Therapy Market Y-o-Y Growth, By Cancer Type, 2023-2031 (%)

Figure 12 Breast Cancer Cancer Type in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 13 Bladder Cancer Cancer Type in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 14 Blood Cancer Cancer Type in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 15 Lung Cancer Cancer Type in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 16 Brain Cancer Cancer Type in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 17 Others Cancer Type in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 18 Global Cancer Stem Cell Therapy Market Y-o-Y Growth, By End User, 2023-2031 (%)

Figure 19 Hospitals End User in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 20 Clinics End User in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 21 Academic and Research Institutes End User in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 22 Others End User in Global Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 23 Global Cancer Stem Cell Therapy Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 24 North America Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 25 North America Cancer Stem Cell Therapy Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 26 North America Cancer Stem Cell Therapy Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 27 North America Cancer Stem Cell Therapy Market Share, By End User, 2023 &amp; 2031 (%)

Figure 28 North America Cancer Stem Cell Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 29 Asia-Pacific Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 30 Asia-Pacific Cancer Stem Cell Therapy Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 31 Asia-Pacific Cancer Stem Cell Therapy Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 32 Asia-Pacific Cancer Stem Cell Therapy Market Share, By End User, 2023 &amp; 2031 (%)

Figure 33 Asia-Pacific Cancer Stem Cell Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 34 Europe Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 35 Europe Cancer Stem Cell Therapy Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 36 Europe Cancer Stem Cell Therapy Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 37 Europe Cancer Stem Cell Therapy Market Share, By End User, 2023 &amp; 2031 (%)

Figure 38 Europe Cancer Stem Cell Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 39 South America Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 40 South America Cancer Stem Cell Therapy Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 41 South America Cancer Stem Cell Therapy Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 42 South America Cancer Stem Cell Therapy Market Share, By End User, 2023 &amp; 2031 (%)

Figure 43 South America Cancer Stem Cell Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 44 Middle East and Africa Cancer Stem Cell Therapy Market Value, 2022-2031 (US$ Million)

Figure 45 Middle East and Africa Cancer Stem Cell Therapy Market Share, By Product Type, 2023 &amp; 2031 (%)

Figure 46 Middle East and Africa Cancer Stem Cell Therapy Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 47 Middle East and Africa Cancer Stem Cell Therapy Market Share, By End User, 2023 &amp; 2031 (%)

Figure 48 Thermo Fisher Scientific, Inc: Financials

Figure 49 Advanced Cell Diagnostics: Financials

Figure 50 Silicon Biosystems: Financials

Figure 51 Celularity Inc: Financials

Figure 52 Gamida Cell Ltd: Financials

Figure 53 Sumitomo Dainippon Pharma Co. Ltd: Financials

Figure 54 Merck KGaA: Financials

Figure 55 Genentech Inc: Financials

Figure 56 Astellas Pharma Inc: Financials

Figure 57 Novadip Biosciences: Financials

Cancer Stem Cell Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Bone Cancer Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 September 12

Starting from

Thymus Cancer Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 November 12

Starting from

Oncology Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 May 21

Starting from

Cancer Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 June 03

Starting from

T-cell-lymphoma Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 October 23

Starting from

Myelofibrosis Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 August 27

Starting from